Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer.
about
Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patientsOsmotic-shock produced by vitrification solutions improves immature human oocytes in vitro maturationAdjuvant gonadotropin releasing hormone analog in gonadotoxic chemotherapy for preservation of fertilityClinical guide to fertility preservation in hematopoietic cell transplant recipientsFertility concerns and preservation strategies in young women with breast cancer.Preserving fertility in patients undergoing treatment for breast cancer: current perspectives.Fertility preservation in female cancer patients: An overview.Variability in the practice of fertility preservation for patients with cancerShort-Term PTEN Inhibition Improves In Vitro Activation of Primordial Follicles, Preserves Follicular Viability, and Restores AMH Levels in Cryopreserved Ovarian Tissue From Cancer PatientsLong-Time Cooling before Cryopreservation Decreased Translocation of Phosphatidylserine (Ptd-L-Ser) in Human Ovarian TissueEffect of Previous Chemotherapy on the Quality of Cryopreserved Human Ovarian Tissue In Vitro.Does adipose tissue-derived stem cell therapy improve graft quality in freshly grafted ovaries?Primordial Follicle Transplantation within Designer Biomaterial Grafts Produce Live Births in a Mouse Infertility ModelNew advances in ovarian autotransplantation to restore fertility in cancer patientsOvarian stimulation protocols for onco-fertility patients.Fertility counseling of young breast cancer patients.The influence of amifostine administration prior to cyclophosphamide on in vitro maturation of mouse oocytes.Preserving Fertility in Children and Adolescents with Cancer.Young female cancer patients' experiences with fertility counselling and fertility preservation-a qualitative small-scale study within the Danish health care setting.SEOM Clinical Guideline of fertility preservation and reproduction in cancer patients (2016).Infertility in reproductive-age female cancer survivors.Anticancer treatments and female fertility: clinical concerns and role of oncologists in oncofertility practice.Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art.Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates.Male fertility and skin diseases.Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin.A Review of the Oncology Patient's Challenges for Utilizing Fertility Preservation Services.Review of fertility preservation issues for young women with breast cancer.The past, present and future of fertility preservation in cancer patients.Serous adenocarcinoma of the ovary diagnosed during ultrasound evaluation for fertility preservation.GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.Ovarian tissue cryopreservation using vitrification and/or in vitro activated technology.Critical Review of Clinical Practice Guidelines for Fertility Preservation in Teenagers and Young Adults with Cancer.Fertility preservation for medical reasons in girls and women: British fertility society policy and practice guideline.Advances in fertility preservation of female patients with hematological malignancies.Ovarian tissue cryopreservation in young females through the Oncofertility Consortium's National Physicians Cooperative.Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis.Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation.Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes†.Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?
P2860
Q28271961-FD106B2F-49AC-4FA0-A5F0-43DB081B6510Q28834259-1344B1D7-3FEB-43D7-8E0B-475609E1CAE2Q33411597-9CC0CB79-63E3-4DD3-B393-BA701515EAF8Q33809651-13E7462E-22FC-4718-A944-B39FBACE8D35Q33814662-22813944-0FA5-43CF-8601-9AE49016591DQ33939688-CB6AAEA1-2CE5-4E80-AC96-DC0DB9DAB18AQ35237851-3E015AD1-402A-4E05-A32B-8396B4C6228AQ35641046-B6A9C776-7482-4F84-B4D6-3F54BE9CDB2CQ35646371-67D755BD-37F6-4E59-A29D-3CAC9C75702AQ35665709-2D7CB49E-9F11-47B8-819C-44B08B3B7D93Q35727027-5BF67BCE-DDE3-46BC-B6DA-F5B3C29B6B34Q36086613-311CE1E0-A9F9-4CE6-A493-6A5D550C4CC8Q36343842-869865ED-AEEF-48C2-BB9F-230012D8B91FQ36490265-5C0D5C36-C1A6-4095-9BC6-4EA0E11304A0Q36648739-33DD3709-8707-4F83-9DB8-6699F7FACE87Q36963384-22CF1229-D79D-4134-822F-49F430847DEEQ37049967-53788921-C2D6-42C5-AC1F-C1EE8369BFFAQ37055811-B25EC3F0-61BC-4497-8DE6-C729037DC0EAQ37397780-7FE11FD5-FA3E-4E09-BAB8-5B28FBAEF93CQ37475179-B6A01978-FF59-47F7-AD40-B19B65487435Q38343285-A253F753-423C-4B95-ABF7-200CC31E3503Q38679872-28A8547D-A778-4C90-BF6B-2CB6CE2820E5Q38835475-F3DEAC8B-2101-4F4B-81A4-DD291DD3CE6AQ38845245-EA7199B9-8063-47CD-B679-A72667B79B50Q38876303-C961E6EB-4ACE-4892-8AD1-249D3609AD23Q38913042-318828B5-2AB9-4A82-B5C6-45BB8F4B11CCQ38928754-EECD6AF2-7689-4DC5-B7A6-8A9E0AF433D2Q38937275-2E13955C-3899-4EF3-9A99-C2F2C247D2A0Q38965305-24466928-6D4A-4922-90E3-C8B7AC6762FDQ39100012-459B2DDA-B167-4CB1-990B-531459E0E373Q40432160-46427783-B5C7-4F1A-8531-7196CB526517Q41600330-C59542B7-15AC-45FE-805A-A06CCF0F2DD1Q43070482-18E278C7-9B65-4B88-B52E-B793F171ECECQ47558016-CD244E33-A0A5-48DA-8B95-6FC32F9F47F0Q47662579-5CF3496F-CC39-4682-8BD6-2AA0A40C7DDAQ47725865-9D8E14FB-8236-4EA7-8FA1-F124588D5548Q47853555-884FE0B5-7DA1-49B1-84D3-C2377CE1F9EDQ48507477-D5EFFA79-269F-422E-9137-2A8844E0E800Q48552463-1BCA5BF3-2B68-4EA4-80F6-3C9BE5952DA4Q48618463-8CDF324D-A6C4-4E69-B56E-920DA381B494
P2860
Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Recommendations for fertility ...... , leukemia, and breast cancer.
@ast
Recommendations for fertility ...... , leukemia, and breast cancer.
@en
type
label
Recommendations for fertility ...... , leukemia, and breast cancer.
@ast
Recommendations for fertility ...... , leukemia, and breast cancer.
@en
prefLabel
Recommendations for fertility ...... , leukemia, and breast cancer.
@ast
Recommendations for fertility ...... , leukemia, and breast cancer.
@en
P2093
P2860
P50
P1476
Recommendations for fertility ...... , leukemia, and breast cancer.
@en
P2093
Bunpei Ishizuka
Chii-Ruey Tzeng
Claus Andersen
Debra Gook
Dror Meirow
Hamish Wallace
ISFP Practice Committee
Marie-Madeleine Dolmans
Outi Hovatta
Pasquale Patrizio
P2860
P2888
P304
P356
10.1007/S10815-012-9786-Y
P577
2012-05-31T00:00:00Z